Renal Biomarkers Market, By Biomarker Type (Functional Biomarker (Serum Creatinine, Serum Cystatin C, Urine Albumin), Up-Regulated Proteins (Neutrophil gelatinase-associated lipocalin, Kidney injury molecule 1, Interleukin 18), Others), By Technique (Enzy

Renal Biomarkers Market, By Biomarker Type (Functional Biomarker (Serum Creatinine, Serum Cystatin C, Urine Albumin), Up-Regulated Proteins (Neutrophil gelatinase-associated lipocalin, Kidney injury molecule 1, Interleukin 18), Others), By Technique (Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass Spectrometry), By End User (Diagnostic Labs, Outpatient Clinics, Research Centers, Hospitals), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and excess fluids from the blood are excreted through urine. However, when an individual is suffering from chronic kidney disease, kidneys cannot perform their natural function and wastes, fluids, and electrolytes build up in the body in excess amounts. Signs and symptoms of chronic kidney disease are not apparent until kidney function becomes significantly impaired. For this purpose various diagnostic tests are performed which involve use of various tests which asses biomarkers to understand functioning of the kidneys. Increase or decrease in values of these biomarkers indicates dysfunction of kidneys.
Restraints of the Global Renal Biomarkers Market
Factors such as low sensitivity and specificity of biomarkers is expected to hinder growth of the global renal biomarkers market. For instance, some renal biomarkers such as L-18 are more specific although are not very sensitive, while other biomarkers such as osteopontin are highly sensitive though they are not specific.
Key features of the study:
This report provides in-depth analysis of the global renal biomarkers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global renal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., Randox Laboratories Ltd., and SphingoTec GmbH.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global renal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Renal Biomarkers Market, By Biomarker Type:
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
Global Renal Biomarkers Market, By Technique:
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
Global Renal Biomarkers Market, By End User:
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
Global Renal Biomarkers Market, By Geography:
North America
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
U.S.
Canada
Europe
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country:
GCC
Israel
Rest of Middle East
Africa
By Biomarker Type
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-Regulated Proteins
Neutrophil gelatinase-associated lipocalin
Kidney injury molecule 1
Interleukin 18
Others
By Technique
Enzyme Linked Immunosorbent Assay
Particle-Enhanced Turbidimetric Immunoassay
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay
Liquid Chromatography-Mass Spectrometry
By End User
Diagnostic Labs
Outpatient Clinics
Research Centers
Hospitals
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Beckman Coulter, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Thermo Fisher Scientific Inc.
Abbott Laboratories
BIOPORTO A/S
Astute Medical, Inc.
Randox Laboratories Ltd.
SphingoTec GmbH
“*” marked represents similar segmentation in other categories in the respective section.